|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 2197 for Fgfr3

<< First    < Previous  |  Next >    Last >>
0.026s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Gene
2261 | FGFR3
Type: gene
Organism: human
•
•
•
•
•
Gene
58129 | fgfr3
Type: gene
Organism: zebrafish
•
•
•
•
•
Gene
712829 | FGFR3
Type: gene
Organism: macaque, rhesus
•
•
•
•
•
Gene
100196923 | fgfr3
Type: gene
Organism: frog, western clawed
•
•
•
•
•
Gene
281769 | FGFR3
Type: gene
Organism: cattle
•
•
•
•
•
Gene
84489 | Fgfr3
Type: gene
Organism: rat
•
•
•
•
•
Gene
488808 | FGFR3
Type: gene
Organism: dog, domestic
•
•
•
•
•
Gene
461067 | FGFR3
Type: gene
Organism: chimpanzee
•
•
•
•
•
Gene
396515 | FGFR3
Type: gene
Organism: chicken
•
•
•
•
•
Protein Coding Gene
MGI:95524 | Fgfr3
Type: protein_coding_gene
Organism: mouse, laboratory
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:5556219
Assay Type: Northern blot
Annotation Date: 2014-04-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1737323
Stage: TS23
Assay Id: MGI:5556256
Age: embryonic day 15.5
Specimen Label: Fgfr3
Detected: true
Specimen Num: 3
•
•
•
•
•
Protein
Q3UNB1
Organism: Mus musculus/domesticus
Length: 140  
Fragment?: false
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6386983
Assay Type: RNase protection
Annotation Date: 2020-01-30
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1783828
Stage: TS28
Assay Id: MGI:6387000
Age: postnatal adult
Image: S2
Specimen Label: Fgfr3 null
Detected: false
Specimen Num: 5
•
•
•
•
•
Publication
20582225 | J:161199
First Author: Su N
Year: 2010
Journal: Int J Biol Sci
Title: Generation of Fgfr3 conditional knockout mice.
Volume: 6
Issue: 4
Pages: 327-32
•
•
•
•
•
Publication
21491541 | J:171616
First Author: Moldrich RX
Year: 2011
Journal: Dev Dyn
Title: Fgfr3 regulates development of the caudal telencephalon.
Volume: 240
Issue: 6
Pages: 1586-99
•
•
•
•
•
Publication
28924384 | J:275043
First Author: Xie Y
Year: 2017
Journal: Int J Biol Sci
Title: FGFR3 deficient mice have accelerated fracture repair.
Volume: 13
Issue: 8
Pages: 1029-1037
•
•
•
•
•
Publication
28230213 | J:287271
 
First Author: Lee YC
Year: 2017
Journal: Sci Rep
Title: Knock-in human FGFR3 achondroplasia mutation as a mouse model for human skeletal dysplasia.
Volume: 7
Pages: 43220
•
•
•
•
•
Publication
29323153 | J:260199
First Author: Shazeeb MS
Year: 2018
Journal: Sci Rep
Title: Skeletal Characterization of the Fgfr3 Mouse Model of Achondroplasia Using Micro-CT and MRI Volumetric Imaging.
Volume: 8
Issue: 1
Pages: 469
•
•
•
•
•
Publication
24048522 | J:213457
First Author: Garcia S
Year: 2013
Journal: Sci Transl Med
Title: Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice.
Volume: 5
Issue: 203
Pages: 203ra124
•
•
•
•
•
Publication
32916123 | J:310477
First Author: Julien A
Year: 2020
Journal: Stem Cell Reports
Title: FGFR3 in Periosteal Cells Drives Cartilage-to-Bone Transformation in Bone Repair.
Volume: 15
Issue: 4
Pages: 955-967
•
•
•
•
•
Publication
26091072 | J:224751
First Author: Zhou S
Year: 2015
Journal: PLoS Genet
Title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
Volume: 11
Issue: 6
Pages: e1005214
•
•
•
•
•
Publication
27729453 | J:237637
First Author: Wen X
Year: 2016
Journal: J Biol Chem
Title: Chondrocyte FGFR3 Regulates Bone Mass by Inhibiting Osteogenesis.
Volume: 291
Issue: 48
Pages: 24912-24921
•
•
•
•
•
Publication
30043421 | J:267607
First Author: Foth M
Year: 2018
Journal: J Pathol
Title: FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation.
Volume: 246
Issue: 3
Pages: 331-343
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:3687188
Assay Type: RNA in situ
Annotation Date: 2006-11-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1910624
Pattern: Regionally restricted
Stage: TS24
Assay Id: MGI:3687189
Age: embryonic day 16.5
Note: Expression was low in prechondrocytes and epiphyseal reserve chondroblasts and upregulated in columnar chondroblasts.
Specimen Label: 7 FGFR3 top
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:3687188
Assay Type: RNA in situ
Annotation Date: 2006-11-09
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1910624
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:3687189
Age: embryonic day 16.5
Specimen Label: 7 FGFR3 bottom
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6451700
Assay Type: Immunohistochemistry
Annotation Date: 2020-08-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3286620
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:6451703
Age: embryonic day 12.5
Specimen Label: S1 FGFR3 E12.5
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6451700
Assay Type: Immunohistochemistry
Annotation Date: 2020-08-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3286621
Pattern: Not Specified
Stage: TS21
Assay Id: MGI:6451703
Age: embryonic day 13.5
Specimen Label: S1 FGFR3 E13.5
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:6451700
Assay Type: Immunohistochemistry
Annotation Date: 2020-08-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3286020
Pattern: Regionally restricted
Stage: TS20
Assay Id: MGI:6451703
Age: embryonic day 12.5
Note: Expression on basal surface of distal airway epithelium.
Specimen Label: S1 FGFR3 E12.5
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:6451700
Assay Type: Immunohistochemistry
Annotation Date: 2020-08-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3286021
Pattern: Regionally restricted
Stage: TS21
Assay Id: MGI:6451703
Age: embryonic day 13.5
Note: Expression on basal surface of distal airway epithelium.
Specimen Label: S1 FGFR3 E13.5
Detected: true
Specimen Num: 2
•
•
•
•
•
Publication
24419316 | J:210100
First Author: Di Rocco F
Year: 2014
Journal: Hum Mol Genet
Title: FGFR3 mutation causes abnormal membranous ossification in achondroplasia.
Volume: 23
Issue: 11
Pages: 2914-25
•
•
•
•
•
Publication
18753255 | J:293843
First Author: Liu S
Year: 2008
Journal: J Am Soc Nephrol
Title: FGFR3 and FGFR4 do not mediate renal effects of FGF23.
Volume: 19
Issue: 12
Pages: 2342-50
•
•
•
•
•
Publication
37345656 | J:338859
 
First Author: Loisay L
Year: 2023
Journal: JCI Insight
Title: Hypochondroplasia gain-of-function mutation in FGFR3 causes defective bone mineralization in mice.
Volume: 8
Issue: 12
•
•
•
•
•
Publication
15784730 | J:99251
First Author: Chen J
Year: 2005
Journal: Blood
Title: Constitutively activated FGFR3 mutants signal through PLCgamma-dependent and -independent pathways for hematopoietic transformation.
Volume: 106
Issue: 1
Pages: 328-37
•
•
•
•
•
Publication
33116259 | J:298585
First Author: Huang JY
Year: 2020
Journal: Sci Rep
Title: Enhanced FGFR3 activity in postmitotic principal neurons during brain development results in cortical dysplasia and axonal tract abnormality.
Volume: 10
Issue: 1
Pages: 18508
•
•
•
•
•
Publication
20673820 | J:166292
First Author: Pannier S
Year: 2010
Journal: Bone
Title: Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia.
Volume: 47
Issue: 5
Pages: 905-15
•
•
•
•
•
Publication
28802681 | J:257075
 
First Author: Osawa Y
Year: 2017
Journal: Bone
Title: Activated FGFR3 promotes bone formation via accelerating endochondral ossification in mouse model of distraction osteogenesis.
Volume: 105
Pages: 42-49
•
•
•
•
•
Publication
18789890 | J:141240
First Author: Su N
Year: 2008
Journal: Biochem Biophys Res Commun
Title: Gain-of-function mutation of FGFR3 results in impaired fracture healing due to inhibition of chondrocyte differentiation.
Volume: 376
Issue: 3
Pages: 454-9
•
•
•
•
•
Publication
30086379 | J:314653
First Author: Kimura T
Year: 2018
Journal: Osteoarthritis Cartilage
Title: Proposal of patient-specific growth plate cartilage xenograft model for FGFR3 chondrodysplasia.
Volume: 26
Issue: 11
Pages: 1551-1561
•
•
•
•
•
Publication
17192470 | J:121934
First Author: Arnaud-Dabernat S
Year: 2007
Journal: Diabetes
Title: FGFR3 is a negative regulator of the expansion of pancreatic epithelial cells.
Volume: 56
Issue: 1
Pages: 96-106
•
•
•
•
•
Publication
31189094 | J:289259
First Author: Kang W
Year: 2019
Journal: Stem Cell Reports
Title: Transient Redirection of SVZ Stem Cells to Oligodendrogenesis by FGFR3 Activation Promotes Remyelination.
Volume: 12
Issue: 6
Pages: 1223-1231
•
•
•
•
•
Publication
27041063 | J:250740
 
First Author: Zhou S
Year: 2016
Journal: Sci Rep
Title: Conditional Deletion of Fgfr3 in Chondrocytes leads to Osteoarthritis-like Defects in Temporomandibular Joint of Adult Mice.
Volume: 6
Pages: 24039
•
•
•
•
•
Publication
22367969 | J:183772
First Author: Mugniery E
Year: 2012
Journal: Hum Mol Genet
Title: An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth.
Volume: 21
Issue: 11
Pages: 2503-13
•
•
•
•
•
Publication
10587515 | J:69849
First Author: Chen L
Year: 1999
Journal: J Clin Invest
Title: Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis.
Volume: 104
Issue: 11
Pages: 1517-25
•
•
•
•
•
Publication
11406607 | J:70061
First Author: Iwata T
Year: 2001
Journal: Hum Mol Genet
Title: Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice.
Volume: 10
Issue: 12
Pages: 1255-64
•
•
•
•
•
Publication
23200862 | J:203653
First Author: Lorget F
Year: 2012
Journal: Am J Hum Genet
Title: Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.
Volume: 91
Issue: 6
Pages: 1108-14
•
•
•
•
•
Publication
35254402 | J:344353
 
First Author: Cornille M
Year: 2022
Journal: J Exp Med
Title: FGFR3 overactivation in the brain is responsible for memory impairments in Crouzon syndrome mouse model.
Volume: 219
Issue: 4
•
•
•
•
•
Publication
15690367 | J:97886
First Author: Dunois-Lardé C
Year: 2005
Journal: Mol Carcinog
Title: Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine.
Volume: 42
Issue: 3
Pages: 142-9
•
•
•
•
•
Publication
9124710 | J:38470
First Author: Usha AP
Year: 1997
Journal: Anim Genet
Title: Dwarfism in Dexter cattle is not caused by the mutations in FGFR3 responsible for achondroplasia in humans.
Volume: 28
Issue: 1
Pages: 55-7
•
•
•
•
•
Publication
18923003 | J:143273
First Author: Matsushita T
Year: 2009
Journal: Hum Mol Genet
Title: FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway.
Volume: 18
Issue: 2
Pages: 227-40
•
•
•
•
•
Publication
15708559 | J:96234
First Author: Inglis-Broadgate SL
Year: 2005
Journal: Dev Biol
Title: FGFR3 regulates brain size by controlling progenitor cell proliferation and apoptosis during embryonic development.
Volume: 279
Issue: 1
Pages: 73-85
•
•
•
•
•
Publication
24657641 | J:212481
First Author: Qi H
Year: 2014
Journal: Biochim Biophys Acta
Title: FGFR3 induces degradation of BMP type I receptor to regulate skeletal development.
Volume: 1843
Issue: 7
Pages: 1237-47
•
•
•
•
•
Publication
29040558 | J:256288
First Author: Martin L
Year: 2018
Journal: Hum Mol Genet
Title: Constitutively-active FGFR3 disrupts primary cilium length and IFT20 trafficking in various chondrocyte models of achondroplasia.
Volume: 27
Issue: 1
Pages: 1-13
•
•
•
•
•
Publication
18061568 | J:128902
First Author: de Frutos CA
Year: 2007
Journal: Dev Cell
Title: Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias.
Volume: 13
Issue: 6
Pages: 872-83
•
•
•
•
•
Publication
23014564 | J:191145
First Author: Jin M
Year: 2012
Journal: Hum Mol Genet
Title: A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia.
Volume: 21
Issue: 26
Pages: 5443-55
•
•
•
•
•
Publication
21139072 | J:172318
First Author: Li H
Year: 2011
Journal: Am J Physiol Endocrinol Metab
Title: Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype.
Volume: 300
Issue: 3
Pages: E508-17
•
•
•
•
•
Publication
11585811 | J:71958
First Author: Wang Q
Year: 2001
Journal: Development
Title: Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains.
Volume: 128
Issue: 19
Pages: 3867-76
•
•
•
•
•
Publication
31662319 | J:292940
First Author: Kuang L
Year: 2020
Journal: Ann Rheum Dis
Title: FGFR3 deficiency enhances CXCL12-dependent chemotaxis of macrophages via upregulating CXCR7 and aggravates joint destruction in mice.
Volume: 79
Issue: 1
Pages: 112-122
•
•
•
•
•
Publication
27506979 | J:238563
First Author: Ota S
Year: 2016
Journal: Hum Mol Genet
Title: HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasia.
Volume: 25
Issue: 19
Pages: 4227-4243
•
•
•
•
•
Publication
10861287 | J:63198
First Author: Iwata T
Year: 2000
Journal: Hum Mol Genet
Title: A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos.
Volume: 9
Issue: 11
Pages: 1603-13
•
•
•
•
•
Publication
17117437 | J:117235
First Author: Hayashi T
Year: 2007
Journal: Dev Dyn
Title: Loss of Fgfr3 leads to excess hair cell development in the mouse organ of Corti.
Volume: 236
Issue: 2
Pages: 525-33
•
•
•
•
•
Publication
19073250 | J:147208
First Author: Pannier S
Year: 2009
Journal: Biochim Biophys Acta
Title: Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia.
Volume: 1792
Issue: 2
Pages: 140-7
•
•
•
•
•
Publication
22072392 | J:179739
First Author: Jonquoy A
Year: 2012
Journal: Hum Mol Genet
Title: A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model.
Volume: 21
Issue: 4
Pages: 841-51
•
•
•
•
•
Publication
15772091 | J:98682
First Author: Logié A
Year: 2005
Journal: Hum Mol Genet
Title: Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
Volume: 14
Issue: 9
Pages: 1153-60
•
•
•
•
•
Publication
32966879 | J:316813
First Author: Ran Q
Year: 2021
Journal: Transplant Cell Ther
Title: Loss of FGFR3 Accelerates Bone Marrow Suppression-Induced Hematopoietic Stem and Progenitor Cell Expansion by Activating FGFR1-ELK1-Cyclin D1 Signaling.
Volume: 27
Issue: 1
Pages: 45.e1-45.e10
•
•
•
•
•
Publication
25432534 | J:219364
First Author: Zhou ZQ
Year: 2015
Journal: Hum Mol Genet
Title: Mutant activated FGFR3 impairs endochondral bone growth by preventing SOX9 downregulation in differentiating chondrocytes.
Volume: 24
Issue: 6
Pages: 1764-73
•
•
•
•
•
Publication
17150206 | J:118802
First Author: Blak AA
Year: 2007
Journal: Dev Biol
Title: Fgfr2 and Fgfr3 are not required for patterning and maintenance of the midbrain and anterior hindbrain.
Volume: 303
Issue: 1
Pages: 231-43
•
•
•
•
•
Publication
12441294 | J:80021
First Author: Pringle NP
Year: 2003
Journal: Development
Title: Fgfr3 expression by astrocytes and their precursors: evidence that astrocytes and oligodendrocytes originate in distinct neuroepithelial domains.
Volume: 130
Issue: 1
Pages: 93-102
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689419
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:6190278
Age: embryonic day 11.5
Specimen Label: Table S2 - E11.5 - Fgfr3
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689421
Pattern: Not Specified
Stage: TS21
Assay Id: MGI:6190278
Age: embryonic day 13.5
Specimen Label: Table S2 - E13.5 - Fgfr3
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689424
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:6190278
Age: embryonic day 15.5
Specimen Label: Table S2 - E15.5 - Fgfr3
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689426
Pattern: Not Specified
Stage: TS26
Assay Id: MGI:6190278
Age: embryonic day 18.5
Specimen Label: Table S2 - E18.5 - Fgfr3
Detected: true
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689428
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6190278
Age: postnatal day 4
Specimen Label: Table S2 - P4 - Fgfr3
Detected: true
Specimen Num: 5
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689428
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6190278
Age: postnatal day 14
Specimen Label: Table S2 - P14 - Fgfr3
Detected: true
Specimen Num: 6
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689428
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6190278
Age: postnatal day 28
Specimen Label: Table S2 - P28 - Fgfr3
Detected: true
Specimen Num: 7
•
•
•
•
•
Publication
20053668 | J:157951
First Author: Su N
Year: 2010
Journal: Hum Mol Genet
Title: Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis.
Volume: 19
Issue: 7
Pages: 1199-210
•
•
•
•
•
Publication
9126476 | J:39496
First Author: Perez-Castro AV
Year: 1997
Journal: Genomics
Title: Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene.
Volume: 41
Issue: 1
Pages: 10-6
•
•
•
•
•
Publication
22843502 | J:187998
First Author: Shung CY
Year: 2012
Journal: Hum Mol Genet
Title: Disruption of a Sox9-β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II.
Volume: 21
Issue: 21
Pages: 4628-44
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:7733440
Assay Type: RNA in situ
Annotation Date: 2024-10-02
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1691022
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:7734645
Age: embryonic day 14.5
Note: Fgfr3 was strongly expressed in the posterior region and not observed in the olfactory bulb.
Specimen Label: 1F
Detected: true
Specimen Num: 2
•
•
•
•
•
Publication
21504907 | J:174242
First Author: Ahmad I
Year: 2011
Journal: Dis Model Mech
Title: K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder.
Volume: 4
Issue: 4
Pages: 548-55
•
•
•
•
•
Publication
16009496 | J:104421
First Author: Jungnickel J
Year: 2005
Journal: Neuroscience
Title: Regulation of neuronal death and calcitonin gene-related peptide by fibroblast growth factor-2 and FGFR3 after peripheral nerve injury: evidence from mouse mutants.
Volume: 134
Issue: 4
Pages: 1343-50
•
•
•
•
•
Publication
- | J:178517
     
First Author: Harris BS
Year: 2011
Journal: MGI Direct Data Submission
Title: A new spontaneous mutation in Fgfr3
•
•
•
•
•
Publication
12960068 | J:85765
First Author: Nakajima A
Year: 2003
Journal: Endocrinology
Title: Expression of fibroblast growth factor receptor-3 (FGFR3), signal transducer and activator of transcription-1, and cyclin-dependent kinase inhibitor p21 during endochondral ossification: differential role of FGFR3 in skeletal development and fracture repair.
Volume: 144
Issue: 10
Pages: 4659-68
•
•
•
•
•
Publication
33370388 | J:299484
First Author: Gonçalves D
Year: 2020
Journal: PLoS One
Title: In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia.
Volume: 15
Issue: 12
Pages: e0244368
•
•
•
•
•
Publication
25231866 | J:217305
First Author: Yamashita A
Year: 2014
Journal: Nature
Title: Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.
Volume: 513
Issue: 7519
Pages: 507-11
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 529
Description: Phosphotyrosine; by FGFR3
Type: modified residue
End: 529
•
•
•
•
•
Publication
10200283 | J:54829
First Author: Wang Y
Year: 1999
Journal: Proc Natl Acad Sci U S A
Title: A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3.
Volume: 96
Issue: 8
Pages: 4455-60
•
•
•
•
•
Publication
33784257 | J:308951
 
First Author: Wagner BM
Year: 2021
Journal: JCI Insight
Title: Prevention of guanylyl cyclase-B dephosphorylation rescues achondroplastic dwarfism.
Volume: 6
Issue: 9
•
•
•
•
•
Publication
10607835 | J:59887
First Author: Segev O
Year: 2000
Journal: Hum Mol Genet
Title: Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice.
Volume: 9
Issue: 2
Pages: 249-58
•
•
•
•
•
Publication
9811582 | J:50292
First Author: Naski MC
Year: 1998
Journal: Development
Title: Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3.
Volume: 125
Issue: 24
Pages: 4977-88
•
•
•
•
•
Publication
15781473 | J:99916
First Author: Davidson D
Year: 2005
Journal: J Biol Chem
Title: Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis.
Volume: 280
Issue: 21
Pages: 20509-15
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6386981
Assay Type: RNase protection
Annotation Date: 2020-01-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1783828
Stage: TS28
Assay Id: MGI:6386998
Age: postnatal adult
Image: S2
Specimen Label: Fgfr3 null
Detected: true
Specimen Num: 5
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6386982
Assay Type: RNase protection
Annotation Date: 2020-01-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1783828
Stage: TS28
Assay Id: MGI:6386999
Age: postnatal adult
Image: S2
Specimen Label: Fgfr3 null
Detected: true
Specimen Num: 5
•
•
•
•
•
Publication
8630492 | J:32991
First Author: Colvin JS
Year: 1996
Journal: Nat Genet
Title: Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
Volume: 12
Issue: 4
Pages: 390-7
•
•
•
•
•
Publication
14699054 | J:88289
First Author: Cho JY
Year: 2004
Journal: Proc Natl Acad Sci U S A
Title: Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia.
Volume: 101
Issue: 2
Pages: 609-14
•
•
•
•
•
Publication
12966031 | J:86376
First Author: Lin T
Year: 2003
Journal: Hum Mol Genet
Title: A central nervous system specific mouse model for thanatophoric dysplasia type II.
Volume: 12
Issue: 21
Pages: 2863-71
•
•
•
•
•
Publication
19086028 | J:144356
First Author: Twigg SR
Year: 2009
Journal: Dev Dyn
Title: Skeletal analysis of the Fgfr3(P244R) mouse, a genetic model for the Muenke craniosynostosis syndrome.
Volume: 238
Issue: 2
Pages: 331-42
•
•
•
•
•
Publication
14962737 | J:96765
First Author: Jungnickel J
Year: 2004
Journal: Mol Cell Neurosci
Title: Fibroblast growth factor receptor 3 signaling regulates injury-related effects in the peripheral nervous system.
Volume: 25
Issue: 1
Pages: 21-9
•
•
•
•
•
Publication
8586414 | J:29913
First Author: Perez-Castro AV
Year: 1995
Journal: Genomics
Title: Genomic organization of the mouse fibroblast growth factor receptor 3 (Fgfr3) gene.
Volume: 30
Issue: 2
Pages: 157-62
•
•
•
•
•
Publication
9032024 | J:38428
First Author: Wuechner C
Year: 1996
Journal: Int J Dev Biol
Title: Developmental expression of splicing variants of fibroblast growth factor receptor 3 (FGFR3) in mouse.
Volume: 40
Issue: 6
Pages: 1185-8
•
•
•
•
•
Publication
29545125 | J:267570
 
First Author: Piombo V
Year: 2018
Journal: Bone
Title: Signaling systems affecting the severity of multiple osteochondromas.
Volume: 111
Pages: 71-81
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom